Teva, Cephalon Sue FDA Over Generic Provigil Exclusivity
Teva Pharmaceuticals USA Inc. and Cephalon Inc. sued the U.S. Food and Drug Administration in Washington federal court Tuesday seeking to bar the agency from robbing Teva of the marketing exclusivity...To view the full article, register now.
Already a subscriber? Click here to view full article